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The conference took place between the 11th and 14th of
May 2017 in the medieval village of Gahro, near Berlin. It was
organized by the Molecular Genetics Laboratory for Poly-
microbial Infections and Biofilms, Charite, Universit€atsmedizin
Berlin. Scientists representing 11 European centers involved in
research on the vaginal microbiome came together to exchange
their opinion over present and future frontiers of research.
2. Is bacterial vaginosis lost in translation?
A key objective of this meeting was to address the multi-
disciplinary recent developments highlighting the role of
multi-species biofilms in the etiology of bacterial vaginosis
(BV). Throughout the meeting, a recurrent question was
asked: When we describe BV, are we talking about the same
thing? In other words, are there different types of BV? Or are
we using the term BV for a different set of etiological con-
ditions with similar symptoms? Per Goran Larsson (Depart-
ment of Obstetrics and Gynecology, Link€oping University
Hospital, 581 85 Link€oping, Sweden) argued that BV research
is now on the rise, but despite the hundreds of yearly pub-
lications, there are still a lot of controversial studies that are
not helping to unravel BV etiology.
Traditionally, vaginal dysbiosis includes Candida vaginitis
[1] Trichomonas vaginitis [2] and BV [3], but as Gilbert
Donders (Department of Obstetrics & Gynecology Antwerp
University, Antwerp, Belgium) points out, other significant
dysbioses are being neglected and can account for significant
consequences for women's health. Donders argued that aerobic
vaginitis (AV) or BV mixed flora could be more predictive of
preterm labor than BV [4]. A major problem with differ-
entiation between BV and other dysbioses is the lack of proper
diagnostic methods, since neither the classical Nugent score nor
the Amsel criteria provide very reliable results (sensitivity and
specificity often below 90%) [5], nor do they add understanding
to the pathogenesis of disease, which is purely descriptive.
Furthermore, Mario Vaneechoutte pointed out the possi-
bility of the existence of different triggers for development of
BV, with the possibility of spontaneous and transientx.doi.org/10.1016/j.resmic.2017.07.002
508/© 2017 Institut Pasteur. Published by Elsevier Masson SAS. All rightsphysiological BV [6] and a sexually transmittable, persistent
BV [7], by means of fragments of biofilms consisting of
Gardnerella and other species [8].
The confusion of attitudes is probably unavoidable as long
as everybody understands something different about BV.
Working with clearly defined entities like Gardnerellosis
(defined as Gardnerella conditioned polymicrobial biofilm
disease) would be more helpful. FISH is highly efficient in the
direct visualization of polymicrobial BV biofilms and their
components, but requires skilled staff, is not available every-
where and is probably over-used for clinical purposes. The
commercially available multiplex qPCR tests based on esti-
mation of the ratio between concentrations of Lactobacillus
spp DNA and Gardnerella vaginalis and Atopobium vaginae
are quick, reliable, adequate and meet clinical needs. Other
diagnostic methods are in progress. Simon Cameron (Imperial
College London, Charing Cross Hospital, London, UK) pre-
sented data on in situ ionization mass spectrometry, which
offers a scope of new possibilities to visualize and investigate
metabolomics of microbiota directly in human tissues.
3. Microbiome diversity and diversity of bacterial species
Novel deep sequencing studies have improved our under-
standing of the vaginal microbiome [9,10]. However, these
studies fail to provide functional or mechanistic evidence to
support a direct causeeeffect link [11]. In fact, as pointed out
by Nuno Cerca, among the few direct functional studies
addressing virulent traits of BV-associated bacteria, often G.
vaginalis stands out as the most promising virulent candidate
[12,13]. Elena Spasibova (D.O. Ott Research Institute of
Obstetrics, Gynecology and Reproductology Mendeleevskaya
line, 3, St. Petersburg, Russia) presented data on the diversity
of vaginal lactobacilli in healthy women and pointed out that
the composition of the vaginal biotope is an indicator of a
woman's reproductive health, with significant differences
between the lactobacilli population usually found in healthy
and BV women [14].
A closely related issue is whether BV exists without
G. vaginalis and whether health can co-exist with G. vaginalis.
Most of the sequence_based investigations demonstrate thatreserved.
903Meeting report / Research in Microbiology 168 (2017) 902e904Gardnerella is obligatorily present in BV. However, depending
on the definition criteria of dysbiosis and diagnostic methods
used, some investigators claim the possibility of Gardner-
ella_negative BV [10,15]. On the other hand, its co-occurrence
in health does not necessarily indicate the inoffensiveness and
regular distribution within a normal population, but more
likely the requirement for additional factors for Gardnerella to
express pathogenicity. G. vaginalis is a common component of
the vaginal microbiota. It is much more abundant in women
with bacterial vaginosis [16]. The phenotypic heterogeneity of
G. vaginalis is well known, and several biotyping and geno-
typing methods have been developed [17,18]. Recent genomic
analysis has revealed four G. vaginalis genome groups, with
great differences between each other [19].
Kira Shalepo (D.O. Ott Research Institute of Obstetrics,
Gynecology and Reproductology Mendeleevskaya line, 3, St.
Petersburg, Russia), in collaboration with Alexander Guschin's
group, followed up on the discussion by presenting detailed
data on the diversity and prevalence of the different G. vagi-
nalis genotypes in healthy and BV women. Since G. vaginalis
is known to establish synergistic relationships with other
bacterial species, Guschin proposed that different G. vaginalis
genotypes could interact synergistically and be responsible for
the development of BV.
4. The polymicrobial biofilm hypothesis
An important milestone in BV research was the discovery
that the different species involved in BV were associated in a
structured polymicrobial biofilm, dominated by G. vaginalis
and often including A. vaginae and several lactobacilli spp.
[20]. Alexander Swidsinski argued that to understand poly-
microbial cultures, we have to investigate them as a structure-
functional unity. Swidsinski proposed that BV biofilms contain
core organisms, which are necessary for propagation, highly
specialized for this task, and disabled for autonomic growth
outside of the consolidated polymicrobial biofilm. He argued
that Gardnerella-driven biofilms may be a transitional state
and the missing link in evolution from isolated living pro-
karyotes to completely interdependent polymicrobial com-
munities, giving rise to eukaryotes. It is unclear which
participants in the polymicrobial BV biofilm belong to the
essential core of the biofilm, which are individual symbionts
or accidental beneficiaries. Besides various Gardnerella gen-
otypes, the most interesting participants seem to be A. vaginae,
Lactobacillus iners and Mycoplasma.
5. Taking home a message
BV is not just amorphous dysbiosis, but rather, a number of
different diseases which still have to be precisely defined
based on pathogenic rather than descriptive criteria and using
proper diagnostic methods. New sequencing and functional
data seem to suggest that Gardnerella is not uniform.
The future may reveal that some of the known genotypes
are, in fact, distinct species. Furthermore, it is now evident that
lactobacilli are not totally beneficial. Some may be involved inpathogenesis of dysbiosis and adverse pregnancy outcome.
This seems to be evident, at least in the case of L. iners. Strong
data indicate that L. iners and AV might be even more strongly
associated with preterm birth than BV.Conflict of interest
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